BioCentury
ARTICLE | Clinical News

Pradaxa dabigatran etexilate regulatory update

February 2, 2015 8:00 AM UTC

The U.K.’s NICE issued final guidance recommending Pradaxa dabigatran etexilate from Boehringer to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) -- 1 of its approved indicat...